4.7 Article

Empirically Based Composite Fracture Prediction Model From the Global Longitudinal Study of Osteoporosis in Postmenopausal Women (GLOW)

Journal

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
Volume 99, Issue 3, Pages 817-826

Publisher

ENDOCRINE SOC
DOI: 10.1210/jc.2013-3468

Keywords

-

Funding

  1. Warner Chilcott Company, LLC
  2. Sanofi
  3. Alliance for Better Bone Health (Procter & Gamble Pharmaceuticals, Sanofi)
  4. Servier
  5. Procter Gamble
  6. Lilly
  7. Nycomed
  8. Acuitas
  9. French Ministry of Health
  10. Merck
  11. Amgen
  12. Kyphon
  13. Novartis
  14. Roche
  15. GE Lunar
  16. Alliance for Better Bone Health
  17. Roche-GSK
  18. Eli Lilly
  19. Warner Chilcott
  20. Pfizer
  21. Daiichi-Sankyo
  22. Roche Diagnostics
  23. (University of Cincinnati) from Amgen
  24. NPS
  25. Eli Lilly Co
  26. Wyeth
  27. Alliance
  28. Medical Research Council [MC_UU_12011/1, MC_UP_A620_1014, U1475000001, MC_U147585824] Funding Source: researchfish
  29. National Institute for Health Research [NF-SI-0508-10082, NF-SI-0513-10085] Funding Source: researchfish

Ask authors/readers for more resources

Context: Several fracture prediction models that combine fractures at different sites into a composite outcome are in current use. However, to the extent individual fracture sites have differing risk factor profiles, model discrimination is impaired. Objective: The objective of the study was to improve model discrimination by developing a 5-year composite fracture prediction model for fracture sites that display similar risk profiles. Design: This was a prospective, observational cohort study. Setting: The study was conducted at primary care practices in 10 countries. Patients: Women aged 55 years or older participated in the study. Intervention: Self-administered questionnaires collected data on patient characteristics, fracture risk factors, and previous fractures. Main Outcome Measure: The main outcome is time to first clinical fracture of hip, pelvis, upper leg, clavicle, or spine, each of which exhibits a strong association with advanced age. Results: Of four composite fracture models considered, model discrimination (c index) is highest for an age-related fracture model (c index of 0.75, 47 066 women), and lowest for Fracture Risk Assessment Tool (FRAX) major fracture and a 10-site model (c indices of 0.67 and 0.65). The unadjusted increase in fracture risk for an additional 10 years of age ranges from 80% to 180% for the individual bones in the age-associated model. Five other fracture sites not considered for the age-associated model (upper arm/shoulder, rib, wrist, lower leg, and ankle) have age associations for an additional 10 years of age from a 10% decrease to a 60% increase. Conclusions: After examining results for 10 different bone fracture sites, advanced age appeared the single best possibility for uniting several different sites, resulting in an empirically based composite fracture risk model.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available